Record NNP B-NP O
date NN I-NP O
: : O O
2077-01-31 CD O B-DATE
LEPROSARIUM NNP B-NP B-HOSPITAL
INPATIENT NNP I-NP O
DIALYSIS NNP I-NP O
ADMIT NNP I-NP O
NOTE NNP I-NP O
Outpatient JJ B-NP O
Nephrologist NNP I-NP O
: : O O
Dr. NNP B-NP O
Mcgee NNP I-NP B-DOCTOR
Outpatient NN B-NP O
Dialysis NNP I-NP O
Unit NNP I-NP O
: : O O
BH WDT O B-HOSPITAL
Estimated VBN B-NP O
dry JJ I-NP O
weight NN I-NP O
: : O O
68.5 CD B-NP O
kg NN I-NP O
Dialysis NNP B-NP O
access NN I-NP O
: : O O
RUE NNP B-NP O
AVF NNP I-NP O
Reason NN B-NP O
for IN B-PP O
admission NN B-NP O
: : O O
hypoglycemia NN B-NP O
HPI NNP B-NP O
: : O O
76 CD B-NP B-AGE
F NNP I-NP O
ESRD NNP I-NP O
on IN B-PP O
HD. NNP B-NP O
Felt NNP I-NP O
"woozy , O O
" `` O O
last JJ B-NP O
night NN I-NP O
and CC O O
found VBD B-VP O
by IN B-PP O
daughter NN B-NP O
to TO B-VP O
be VB I-VP O
confused VBN I-VP O
. . O O
Daughter NNP B-NP O
called VBD B-VP O
911 CD B-NP O
and CC I-NP O
FS NNS I-NP O
glucose JJ B-ADJP O
30 CD B-NP O
. . O O
Pt NNP B-NP O
has VBZ B-VP O
had VBN I-VP O
recurrent JJ B-NP O
episodes NNS I-NP O
of IN B-PP O
hypoglycemia NN B-NP O
- : O O
says VBZ B-VP O
b/c IN B-SBAR O
she PRP B-NP O
"does VBZ B-VP O
n't RB I-VP O
want VB I-VP O
to TO I-VP O
eat VB I-VP O
" '' O O
. . O O
She PRP B-NP O
says VBZ B-VP O
she PRP B-NP O
has VBZ B-VP O
an DT B-NP O
endocrinologist NN I-NP O
, , O O
Dr. NNP B-NP O
Hayes NNP I-NP B-DOCTOR
, , O O
but CC O O
does VBZ B-VP O
not RB I-VP O
remember VB I-VP O
where WRB B-ADVP O
the DT B-NP O
office NN I-NP O
is VBZ B-VP O
located VBN I-VP O
. . O O
She PRP B-NP O
takes VBZ B-VP O
insulin NN B-NP O
once RB I-NP O
a DT B-NP O
day NN I-NP O
( -LRB- I-NP O
30u FW I-NP O
NPH NNP I-NP O
and CC O O
10u CD B-NP O
R) NNP I-NP O
. . I-NP O
ROS NNP I-NP O
otherwise RB I-NP O
negative JJ I-NP O
in IN B-PP O
detail NN B-NP O
. . O O
Past NNP B-NP O
Medical NNP I-NP O
History NNP I-NP O
: : O O
ESRD NNP B-NP O
presumed VBD B-VP O
2/2 CD B-NP O
type NN I-NP O
2 CD I-NP O
DM . O O
- : O O
on IN B-PP O
HD NNP B-NP O
since IN B-PP O
2075 CD B-NP B-DATE
, , O O
T NNP B-NP B-DATE
T NNP I-NP B-DATE
S NNP I-NP B-DATE
Type NN B-NP O
2 CD I-NP O
DM NNP I-NP O
( -LRB- I-NP O
Insulin-dependent NN I-NP O
) -RRB- O O
- : O O
multiple JJ B-NP O
episodes NNS I-NP O
of IN B-PP O
hypoglycemia NN B-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
asthma NN B-NP O
- : O O
no DT B-NP O
intubations NNS I-NP O
d/t IN B-PP O
asthma DT B-NP O
exacerbation NN I-NP O
, , O O
has VBZ B-VP O
previously RB I-VP O
been VBN I-VP O
on IN B-PP O
steroids NNS B-NP O
stroke/TIA NNS B-NP O
in IN B-PP O
past NN B-NP O
seizure NN B-NP O
2069 CD I-NP B-DATE
, , O O
unclear JJ B-NP O
etiology NN I-NP O
multinodular JJ B-NP O
goiter NN I-NP O
HTN . O O
hyperlipidemia NN B-NP O
Past NNP B-NP O
Surgical NNP I-NP O
History NNP I-NP O
: : O O
s/p NN B-NP O
TAH-BSO NN I-NP O
Vascular JJ B-NP O
access NN I-NP O
history NN I-NP O
: : O O
R NN B-NP O
brachiocephalic NN I-NP O
fistula NN I-NP O
11/75 CD I-NP B-DATE
after IN B-PP O
3 CD B-NP O
prior RB I-NP O
failed VBN I-NP O
attempts NNS I-NP O
at IN B-PP O
access NN B-NP O
- : O O
given VBN B-VP O
high JJ B-NP O
risk NN I-NP O
of IN B-PP O
further JJ B-NP O
thrombosis NN I-NP O
, , O O
started VBD B-VP O
on IN B-PP O
coumadin NN B-NP O
11/75 CD I-NP B-DATE
- : O O
negative JJ B-NP O
hypercoaguable JJ I-NP O
w/u NN I-NP O
as IN B-PP O
per IN B-PP O
LMR NNP B-NP O
notes NNS I-NP O
Allergies NNP B-NP O
: : O O
NKDA NNP O O
Medications NNS B-NP O
: : O O
insulin NN B-NP O
methyldopa NN B-NP O
250mg CD I-NP O
qd NN I-NP O
lisinopril NN B-NP O
10mg CD I-NP O
qd NN I-NP O
diltiazem NN B-NP O
300mg CD I-NP O
qd NN I-NP O
pravastatin NN B-NP O
10mg CD I-NP O
qhs NNS I-NP O
Nephrocaps RB O O
heparin IN B-PP O
5000u CD B-NP O
bid NN I-NP O
colace NN B-NP O
100mg CD I-NP O
bid NN I-NP O
Social NNP B-NP O
History NNP I-NP O
: : O O
40 CD B-NP O
pack-years NNS I-NP O
, , O O
2-3 CD B-NP O
EtOH NNP I-NP O
drink/week NN I-NP O
, , O O
lives VBZ B-VP O
alone RB B-ADVP O
. . O O
Family NNP B-NP O
History NN I-NP O
: : O O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
Weight NNP B-NP O
: : O O
72.8kg CD O O
Temp NNP B-NP O
: : O O
98.4 CD O O
BP NNP B-NP O
: : O O
150/8 CD B-NP O
2 CD I-NP O
HR NNP B-NP O
: : O O
91 CD O O
RR NN B-NP O
: : O O
22 CD O O
O2 NNP B-NP O
sat VBD B-VP O
100 CD B-NP O
% NN I-NP O
Gen NNP B-NP O
: : O O
Obese JJ B-NP O
AA NNP I-NP O
woman NN I-NP O
in IN B-PP O
NAD. NNP B-NP O
HEENT NNP B-NP O
: : O O
sclerae NNS B-NP O
non-icteric JJ B-ADVP O
, , O O
O&P RB B-ADVP O
clear JJ B-NP O
and CC I-NP O
moist JJ I-NP O
Neck NNP B-NP O
: : O O
supple NN B-NP O
, , O O
no DT B-NP O
LAD NN I-NP O
, , O O
JVP NNP B-NP O
elevated VBD B-LST O
Lungs NNP B-NP O
: : O O
CTA NNP B-NP O
b/l CC O O
Cor NNP B-NP O
: : O O
regular JJ B-NP O
, , I-NP O
s1s2 NN I-NP O
, , O O
no DT B-NP O
m/c/r/g NN I-NP O
Abd NNP B-NP O
: : B-VP O
soft JJ B-ADJP O
, , O O
NTND NNP B-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , O O
no DT B-NP O
abdominal NN I-NP O
bruits NNS I-NP O
Ext JJ B-NP O
: : O O
no DT B-NP O
edema NN I-NP O
in IN B-PP O
LE JJ B-NP O
b/l NN I-NP O
, , O O
2+ JJ B-NP O
pulses NNS I-NP O
distally RB B-LST O
Skin NNP B-NP O
: : O O
warm JJ B-NP O
, , I-NP O
smooth JJ I-NP O
, , O O
no DT B-NP O
rashes NNS I-NP O
Back RB B-ADVP O
: : O O
no NN B-NP O
CVAT NN I-NP O
Vascular JJ B-NP O
access NN I-NP O
: : O O
site NN B-NP O
clean JJ I-NP O
and CC O O
without IN B-PP O
inflammation NN B-NP O
, , I-NP O
systolic JJ I-NP O
and CC I-NP O
diastolic JJ I-NP O
bruit NN I-NP O
present NN I-NP O
LABS NNP B-NP O
: : O O
Date/Time NNP B-NP O
WBC NNP I-NP O
HGB NNP I-NP O
HCT NNP I-NP O
MCV NNP I-NP O
01/31/2077 CD B-NP B-DATE
8.15 CD I-NP O
11.5 CD I-NP O
( -LRB- B-PP O
# # B-NP O
) -RRB- I-NP O
34.7 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
87.3 CD O O
Date/Time NNP B-NP O
PLT NNP I-NP O
01/31/2077 CD B-NP B-DATE
231 CD I-NP O
Date/Time NNP B-NP O
UA-GLUC NNP I-NP O
UA-KET NNP I-NP O
UA-SPGR NNP I-NP O
UA-BLD NNP I-NP O
01/31/2077 CD B-NP B-DATE
TR NNP I-NP O
NEG NNP I-NP O
1.009 CD I-NP O
1+ . O O
Date/Time NNP B-NP O
UA-PH NNP I-NP O
UA-PROT NNP I-NP O
UA-NIT NNP I-NP O
UA-WBC . O O
01/31/2077 CD B-NP B-DATE
8.0 CD I-NP O
2+ JJ I-NP O
NEG NNP I-NP O
NEG NNP I-NP O
Date/Time NNP B-NP O
UAS-BACT NNP I-NP O
01/31/2077 CD B-NP B-DATE
TR NN I-NP O
Date/Time NNP B-NP O
NA NNP I-NP O
K NNP I-NP O
CL NN I-NP O
CO2 . O O
01/31/2077 CD B-NP B-DATE
137 CD I-NP O
5.1 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
95 CD I-NP O
( -LRB- B-PP O
* NN B-NP O
) -RRB- I-NP O
27 CD O O
01/31/2077 CD B-NP B-DATE
134 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
6.2 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
94 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
25 CD O O
01/31/2077 CD B-NP B-DATE
136 CD I-NP O
5.8 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- B-PP O
97 CD B-NP O
( -LRB- I-NP O
* NN B-NP O
) -RRB- I-NP O
20 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
Date/Time NNP B-NP O
BUN NNP I-NP O
CRE NNP I-NP O
EGFR NNP I-NP O
GLU . O O
01/31/2077 CD B-NP B-DATE
49 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
8.0 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
5 CD I-NP O
68 CD O O
01/31/2077 CD B-NP B-DATE
43 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
8.0 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
5 CD I-NP O
83 CD O O
Date/Time NNP B-NP O
ANION NN I-NP O
01/31/2077 CD B-NP B-DATE
15 CD I-NP O
Date/Time NNP B-NP O
CA NNP I-NP O
PHOS NNP I-NP O
MG NNP I-NP O
01/31/2077 CD B-NP B-DATE
10.2 CD I-NP O
1.9 CD O O
01/31/2077 CD B-NP B-DATE
10.6 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
5.8 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
2.0 CD O O
Date/Time NNP B-NP O
CK NNP I-NP O
CK-MB NNP I-NP O
TROP-I . O O
01/31/2077 CD B-NP B-DATE
insufficient JJ I-NP O
blood NN I-NP O
Date/Time NNP B-NP O
PT NNP I-NP O
PT-INR NNP I-NP O
PTT NNP I-NP O
01/31/2077 CD B-NP B-DATE
15.8 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
1.3 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
28.6 CD I-NP O
( -LRB- B-PP O
# # B-NP O
) -RRB- O O
Blood NN B-NP O
cultures NNS I-NP O
negative JJ B-ADJP O
to TO B-PP O
date NN B-NP O
( -LRB- B-NP O
01/31/77 CD I-NP B-DATE
) -RRB- O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
: : O O
76 CD B-NP B-AGE
F NNP I-NP O
ESRD NNP I-NP O
presumed VBD B-VP O
from IN B-PP O
Type NNP B-NP O
2 CD I-NP O
DM NNP I-NP O
, , O O
now RB B-VP O
admitted VBN I-VP O
for IN B-PP O
hypoglycemia NN B-NP O
. . O O
1 LS O O
. . B-NP O
DM NNP I-NP O
: : O O
Check VB B-VP O
HbA1c JJ B-ADJP O
. . O O
Endocrine NNP O O
to TO B-VP O
see VB I-VP O
, , O O
given VBN B-VP O
recurrent JJ B-NP O
hypoglycemia NN I-NP O
. . B-NP O
Nutrition NN I-NP O
to TO B-VP O
see VB I-VP O
. . O O
2. DT B-NP O
HD NNP I-NP O
today NN I-NP O
, , O O
as IN B-PP O
per IN B-PP O
usual JJ B-NP O
schedule NN I-NP O
. . O O
Will MD B-VP O
check VB I-VP O
iron NN B-NP O
studies NNS I-NP O
, , O O
PTH NNP B-NP O
, , O O
25OH NNP B-NP O
Vit NNP I-NP O
D NNP I-NP O
, , O O
URR NNP B-NP O
. . O O
3. CD B-NP O
Hyperkalemia NNP I-NP O
: : O O
Recirculation NNP B-NP O
studies NNS I-NP O
with IN B-PP O
HD NNP B-NP O
today NN B-NP O
. . O O
4 CD B-LST O
. . O O
CAD NNP B-NP O
risk NN I-NP O
: : O O
Check VB B-VP O
fasting VBG B-NP O
lipids NNS I-NP O
, , O O
start VB B-VP O
ECASA NNP B-NP O
81mg CD I-NP O
qd NN I-NP O
, , O O
wean JJ B-NP O
diltiazem NN I-NP O
and CC O O
methyldopa NN B-NP O
and CC I-NP O
increase NN I-NP O
lisinopril NN I-NP O
as IN B-SBAR O
tolerated VBN B-VP O
by IN B-PP O
BP. NNP B-NP O
Would MD B-VP O
not RB I-VP O
start VB I-VP O
beta-blocker NN B-NP O
at IN B-PP O
present JJ B-NP O
until IN B-PP O
hypoglycemic JJ B-NP O
episodes NNS I-NP O
resolved VBD B-VP O
. . O O
5 CD B-NP O
. . O O
INR NNP B-NP O
: : O O
Aiming VBG B-VP O
for IN B-PP O
INR NNP B-NP O
1.5-2 CD I-NP O
- : O O
adjust VBP B-VP O
coumadin NN B-NP O
accordingly RB B-ADVP O
. . O O
6 CD B-NP O
. . O O
PO4 NNP B-NP O
: : O O
Start VB B-VP O
Phoslo NNP B-NP O
667mg CD I-NP O
po NN I-NP O
tid JJ B-ADJP O
with IN B-PP O
meals NNS B-NP O
. . O O
6 CD B-NP O
. . O O
Dispo NNP B-NP O
: : O O
Needs NNS B-NP O
social JJ B-NP O
work NN I-NP O
, , O O
PT NNP B-NP O
, , O O
OT NNP B-NP O
to TO B-VP O
see VB I-VP O
, , O O
as IN B-NP O
does VBZ B-VP O
not RB I-VP O
appear VB I-VP O
to TO I-VP O
be VB I-VP O
safe JJ B-ADJP O
at IN B-PP O
home NN B-NP O
. . O O
Lois NNP B-NP B-DOCTOR
Ochs NNS I-NP I-DOCTOR
Renal NNP B-NP O
Fellow NNP I-NP O
48324 CD O B-PHONE
